Weitere Artikel dieser Ausgabe durch Wischen aufrufen
Sarcopenia and osteoporosis share an underlying pathology and reinforce each other in terms of negative outcomes.
To evaluate the extent of concomitance of sarcopenia as defined by the European Working Group on Sarcopenia in Older People (EWGSOP) and osteoporosis as defined by the World Health Organization (WHO) in geriatric inpatients and their relationship to nutritional and functional status.
A cross-sectional analysis of geriatric inpatients from the sarcopenia in geriatric elderly (SAGE) study. Measurements included dual X‑ray absorptiometry for bone mineral density and appendicular muscle mass; gait speed and hand grip strength, the Barthel index, body mass index (BMI) and the mini nutritional assessment short form (MNA-SF).
Of the 148 patients recruited for SAGE, 141 (84 women, 57 men; mean age 80.6 ± 5.5 years) had sufficient data to be included in this ancillary investigation: 22/141 (15.6%) were only osteoporotic, 19/141 (13.5%) were only sarcopenic and 20/141 (14.2%) osteosarcopenic (i.e. both sarcopenia and osteoporosis). The prevalence of osteoporosis was higher in sarcopenic than in non-sarcopenic individuals (51.3% vs. 21.6%, p < 0.001). Sarcopenic, osteoporotic and osteosarcopenic subjects had a lower BMI, MNA-SF, handgrip and gait speed (p < 0.05) than the reference group (those neither osteoporotic nor sarcopenic, n = 80). The Barthel index was lower for sarcopenic and osteosarcopenic (p < 0.05) but not for osteoporotic (p = 0.07) subjects. The BMI and MNA-SF were lower in osteosarcopenia compared to sarcopenia or osteoporosis alone (p < 0.05) while there were no differences in functional criteria.
Osteoporosis and sarcopenia are linked to nutritional deficits and reduced function in geriatric inpatients. Co-occurrence (osteosarcopenia) is common and associated with a higher degree of malnutrition than osteoporosis or sarcopenia alone.
Drey M, Sieber C, Bertsch T, Bauer J (2016) Schmidmaier R. Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res 28:895–899 CrossRef
Laurent M, Dubois V, Claessens F et al (2016) Muscle-bone interaction: from experimental models to the clinic? A critical update. J Mol Cell Endocrinol 432:14–36 CrossRef
Ng A, Duque G (2010) Osteoporosis as a lipotoxic disease. Bonekey Osteovision 7:108–123
Hirschfeld HP, Kinsella R, Duque G (2017) Osteosarcopenia: where muscle bone and fat collide. Osteoporos Int 28:2781–2790 CrossRef
Crepaldi G, Maggi S (2005) Sarcopenia and osteoporosis a hazardous duet. J Endocrinol Investig 28:66–68 CrossRef
Reginster J, Beaudart C, Buckinx F, Bruyere O (2016) Osteoporosis and sarcopenia: two diseases or one? Curr Opin Clin Nutr Metab Care 19(1):31–36 CrossRef
Huo YR, Suriyaarachchi P, Gomez F et al (2015) Comprehensive nutritional status in sarco-osteopenic older fallers. J Nutr Health Aging 19(4):474–480 CrossRef
Baumgartner R, Koehler K, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763 CrossRef
WHO Scientific Group (2003) Prevention and management of osteoporosis. World health organ tech Rep Ser 921:1–164
Wang YJ, Wang Y, Zhan JK et al (2015) Sarco-osteoporosis: prevalence and association with frailty in Chinese community-dwelling older aldults. Int J Endocrinol 48:29–40
Von Renteln-Kruse W, Ebner D (2003) Merkmale hospitalisierter geriatrischer Patienten. Z Gerontol Geriatr 36:223–232
Locquet M, Beaudart C, Reginster JY et al (2017) Prevalence of concomitant bone and muscle wasting in elderly women from the Sarco PhAge Cohort: preliminary results. J Frailty Aging 6(1):12–17
- Sarcopenia and osteoporosis are interrelated in geriatric inpatients
- Springer Medizin
Zeitschrift für Gerontologie und Geriatrie
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269